RU2013151090A - Питательные композиции, содержащие альфа-гидроксиизокапроновую кислоту и эйкозапентаеновую кислоту - Google Patents
Питательные композиции, содержащие альфа-гидроксиизокапроновую кислоту и эйкозапентаеновую кислоту Download PDFInfo
- Publication number
- RU2013151090A RU2013151090A RU2013151090/13A RU2013151090A RU2013151090A RU 2013151090 A RU2013151090 A RU 2013151090A RU 2013151090/13 A RU2013151090/13 A RU 2013151090/13A RU 2013151090 A RU2013151090 A RU 2013151090A RU 2013151090 A RU2013151090 A RU 2013151090A
- Authority
- RU
- Russia
- Prior art keywords
- nutritional composition
- acid
- composition according
- per day
- protein
- Prior art date
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract 29
- 239000000203 mixture Substances 0.000 title claims abstract 28
- 239000002253 acid Substances 0.000 title 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims abstract 11
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims abstract 11
- 229960002173 citrulline Drugs 0.000 claims abstract 11
- 235000013477 citrulline Nutrition 0.000 claims abstract 11
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract 8
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract 8
- 239000006014 omega-3 oil Substances 0.000 claims abstract 8
- LVRFTAZAXQPQHI-RXMQYKEDSA-N (R)-2-hydroxy-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](O)C(O)=O LVRFTAZAXQPQHI-RXMQYKEDSA-N 0.000 claims abstract 6
- LVRFTAZAXQPQHI-UHFFFAOYSA-N alpha-hydroxyisocaproic acid Natural products CC(C)CC(O)C(O)=O LVRFTAZAXQPQHI-UHFFFAOYSA-N 0.000 claims abstract 6
- 108020004414 DNA Proteins 0.000 claims abstract 5
- 239000002773 nucleotide Substances 0.000 claims abstract 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract 5
- 229920002477 rna polymer Polymers 0.000 claims abstract 5
- 102000053602 DNA Human genes 0.000 claims abstract 4
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 claims abstract 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract 4
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 claims abstract 4
- 235000013311 vegetables Nutrition 0.000 claims abstract 3
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims abstract 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims abstract 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims abstract 2
- 241000195493 Cryptophyta Species 0.000 claims abstract 2
- 241000239366 Euphausiacea Species 0.000 claims abstract 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims abstract 2
- 235000021323 fish oil Nutrition 0.000 claims abstract 2
- 235000004426 flaxseed Nutrition 0.000 claims abstract 2
- 235000014571 nuts Nutrition 0.000 claims abstract 2
- 235000018102 proteins Nutrition 0.000 claims 13
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 108010046377 Whey Proteins Proteins 0.000 claims 4
- 102000014171 Milk Proteins Human genes 0.000 claims 3
- 108010011756 Milk Proteins Proteins 0.000 claims 3
- 102000007544 Whey Proteins Human genes 0.000 claims 3
- 239000005018 casein Substances 0.000 claims 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims 3
- 235000021240 caseins Nutrition 0.000 claims 3
- 235000021239 milk protein Nutrition 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- 102000008934 Muscle Proteins Human genes 0.000 claims 2
- 108010074084 Muscle Proteins Proteins 0.000 claims 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims 2
- 241000209140 Triticum Species 0.000 claims 2
- 235000021307 Triticum Nutrition 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 229940024606 amino acid Drugs 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- -1 caseinates Chemical compound 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims 2
- 229960000310 isoleucine Drugs 0.000 claims 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- 235000021119 whey protein Nutrition 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- GTBJRWFFEQJCHN-REOHCLBHSA-N (2s)-3-hydroxy-2-(hydroxyamino)propanoic acid Chemical compound OC[C@H](NO)C(O)=O GTBJRWFFEQJCHN-REOHCLBHSA-N 0.000 claims 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims 1
- 235000017060 Arachis glabrata Nutrition 0.000 claims 1
- 244000105624 Arachis hypogaea Species 0.000 claims 1
- 235000010777 Arachis hypogaea Nutrition 0.000 claims 1
- 235000018262 Arachis monticola Nutrition 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 240000002900 Arthrospira platensis Species 0.000 claims 1
- 235000016425 Arthrospira platensis Nutrition 0.000 claims 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- 206010065687 Bone loss Diseases 0.000 claims 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims 1
- 235000006008 Brassica napus var napus Nutrition 0.000 claims 1
- 240000000385 Brassica napus var. napus Species 0.000 claims 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims 1
- 240000008620 Fagopyrum esculentum Species 0.000 claims 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 claims 1
- 244000043158 Lens esculenta Species 0.000 claims 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- CNIUEVQJABPUIJ-QMMMGPOBSA-N N-hydroxytyrosine Chemical compound ON[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNIUEVQJABPUIJ-QMMMGPOBSA-N 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 108010084695 Pea Proteins Proteins 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 240000004713 Pisum sativum Species 0.000 claims 1
- 235000016816 Pisum sativum subsp sativum Nutrition 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 208000026214 Skeletal muscle atrophy Diseases 0.000 claims 1
- 235000002595 Solanum tuberosum Nutrition 0.000 claims 1
- 244000061456 Solanum tuberosum Species 0.000 claims 1
- 108010073771 Soybean Proteins Proteins 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 239000005862 Whey Substances 0.000 claims 1
- 240000008042 Zea mays Species 0.000 claims 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 1
- 229920002494 Zein Polymers 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 229930013930 alkaloid Natural products 0.000 claims 1
- 235000021120 animal protein Nutrition 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 235000009697 arginine Nutrition 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 229940009098 aspartate Drugs 0.000 claims 1
- 230000037208 balanced nutrition Effects 0.000 claims 1
- 235000019046 balanced nutrition Nutrition 0.000 claims 1
- 150000005693 branched-chain amino acids Chemical class 0.000 claims 1
- 235000021466 carotenoid Nutrition 0.000 claims 1
- 150000001747 carotenoids Chemical class 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000005822 corn Nutrition 0.000 claims 1
- 235000012754 curcumin Nutrition 0.000 claims 1
- 229940109262 curcumin Drugs 0.000 claims 1
- 239000004148 curcumin Substances 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims 1
- 244000013123 dwarf bean Species 0.000 claims 1
- 229930003935 flavonoid Natural products 0.000 claims 1
- 235000017173 flavonoids Nutrition 0.000 claims 1
- 150000002215 flavonoids Chemical class 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 229960002591 hydroxyproline Drugs 0.000 claims 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 239000000693 micelle Substances 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000035764 nutrition Effects 0.000 claims 1
- 235000019702 pea protein Nutrition 0.000 claims 1
- 235000020232 peanut Nutrition 0.000 claims 1
- 150000002989 phenols Chemical class 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 235000002378 plant sterols Nutrition 0.000 claims 1
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 1
- 238000001243 protein synthesis Methods 0.000 claims 1
- 235000005875 quercetin Nutrition 0.000 claims 1
- 229960001285 quercetin Drugs 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 208000001076 sarcopenia Diseases 0.000 claims 1
- 230000025185 skeletal muscle atrophy Effects 0.000 claims 1
- 229940001941 soy protein Drugs 0.000 claims 1
- 229940082787 spirulina Drugs 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 150000003464 sulfur compounds Chemical class 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 229960003080 taurine Drugs 0.000 claims 1
- 150000003505 terpenes Chemical class 0.000 claims 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims 1
- 230000014616 translation Effects 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 235000018648 unbalanced nutrition Nutrition 0.000 claims 1
- 239000005019 zein Substances 0.000 claims 1
- 229940093612 zein Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/70—Wind energy
- Y02E10/72—Wind turbines with rotation axis in wind direction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Pediatric Medicine (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
Abstract
1. Питательная композиция, содержащая эффективное количество α-гидроксиизокапроновой кислоты и эффективное количество цитруллина.2. Питательная композиция по п.1, в которой α-гидроксиизокапроновая кислота присутствует в количестве от 2 г до 10 г, предпочтительно 1,5 г, или вводится индивидууму с тем, чтобы обеспечить его от 0,15 до 10 г α-гидроксиизокапроновой кислоты в сутки, предпочтительно от 2 г до 10 г в сутки, более предпочтительно - примерно от 0,5 г до 5 г в сутки.3. Питательная композиция по п.1, в которой цитруллин присутствует в количестве от 4 г до 7 г или вводится индивидууму с тем, чтобы обеспечить его от 1 г до 15 г цитруллина в сутки, более предпочтительно от 2 г до 15 г цитруллина в сутки, даже более предпочтительно от 2 г до 7 г в сутки, еще более предпочтительно от 2 г до 5 г цитруллина в сутки.4. Питательная композиция по п.1, которая дополнительно содержит источник ω-3 жирных кислот, который выбирается из группы, состоящей из рыбьего жира, криля, растительных источников, содержащих ω-3 жирные кислоты, льняного семени, орехов, водорослей и их комбинаций.5. Питательная композиция по п.4, в которой ω-3 жирные кислоты выбираются из группы, включающей α-линоленовую кислоту (ALA), докозагексаеновую кислоту (DHA), стеаридоновую кислоту (SDA), эйкозапентаеновая кислота (ЕРА) и их комбинации.6. Питательная композиция по п.4, в которой ω-3 жирные кислоты обеспечиваются в количестве от 0,25 г до 5,0 г в сутки, предпочтительно от 1,0 до 3,0 г в сутки.7. Питательная композиция по п.1, которая дополнительно содержит по меньшей мере один нуклеотид, выбранный из группы, состоящей из субъединицы дезоксирибонуклеиновой кислоты (ДНК), субъединицы рибонуклеиновой к�
Claims (19)
1. Питательная композиция, содержащая эффективное количество α-гидроксиизокапроновой кислоты и эффективное количество цитруллина.
2. Питательная композиция по п.1, в которой α-гидроксиизокапроновая кислота присутствует в количестве от 2 г до 10 г, предпочтительно 1,5 г, или вводится индивидууму с тем, чтобы обеспечить его от 0,15 до 10 г α-гидроксиизокапроновой кислоты в сутки, предпочтительно от 2 г до 10 г в сутки, более предпочтительно - примерно от 0,5 г до 5 г в сутки.
3. Питательная композиция по п.1, в которой цитруллин присутствует в количестве от 4 г до 7 г или вводится индивидууму с тем, чтобы обеспечить его от 1 г до 15 г цитруллина в сутки, более предпочтительно от 2 г до 15 г цитруллина в сутки, даже более предпочтительно от 2 г до 7 г в сутки, еще более предпочтительно от 2 г до 5 г цитруллина в сутки.
4. Питательная композиция по п.1, которая дополнительно содержит источник ω-3 жирных кислот, который выбирается из группы, состоящей из рыбьего жира, криля, растительных источников, содержащих ω-3 жирные кислоты, льняного семени, орехов, водорослей и их комбинаций.
5. Питательная композиция по п.4, в которой ω-3 жирные кислоты выбираются из группы, включающей α-линоленовую кислоту (ALA), докозагексаеновую кислоту (DHA), стеаридоновую кислоту (SDA), эйкозапентаеновая кислота (ЕРА) и их комбинации.
6. Питательная композиция по п.4, в которой ω-3 жирные кислоты обеспечиваются в количестве от 0,25 г до 5,0 г в сутки, предпочтительно от 1,0 до 3,0 г в сутки.
7. Питательная композиция по п.1, которая дополнительно содержит по меньшей мере один нуклеотид, выбранный из группы, состоящей из субъединицы дезоксирибонуклеиновой кислоты (ДНК), субъединицы рибонуклеиновой кислоты (РНК), полимерных форм ДНК и РНК, дрожжевой РНК и их комбинаций, где меньшей мере один нуклеотид является экзогенным нуклеотидом.
8. Питательная композиция по п.7, в которой нуклеотид обеспечивается в количестве от 0,5 г до 3 г в сутки.
9. Питательная композиция по п.1, которая дополнительно содержит фитонутриент, выбранный из группы, состоящей из флавоноидов, родственных фенольных соединений, полифенольных соединений, терпеноидов, алкалоидов, серосодержащих соединений, каротиноидов, растительных стеринов, кверцетина, куркумина, лимонина и их комбинаций.
10. Питательная композиция по п.1, которая дополнительно содержит источник белка, где источник белка обеспечивает питательную композицию по меньшей мере 10 г высококачественного белка.
11. Питательная композиция по п.10, в которой источник белка выбираются из группы молочных белков, состоящей из казеина, мицеллярного казеина, казеинатов, гидролизата казеина, молочной сыворотки, сывороточно-белковых гидролизатов, сывороточно-белковых концентратов, сывороточно-белковых изолятов, мицелл белка молочной сыворотки, молочно-белкового концентрата, молочно-белкового изолята и их комбинаций; группы растительных белков, состоящей соевого белка, белка гороха, белка канолы, пшеничного и фракционированного пшеничного белков, кукурузного белка, включая зеин, белков риса, белков овса, белков картофеля, белков арахиса, порошка зеленого горошка, порошка зеленой фасоли, спирулины, белков, полученных из овощей, бобов, гречихи, чечевицы, одноклеточных белков и их комбинаций; животных белков, искусственных белков и их комбинаций.
12. Питательная композиция по п.1, которая дополнительно содержит аминокислоту, выбранную из группы, состоящей из аланина, аргинина, аспарагина, аспартата, цитруллина, цистеина, глутамата, глутамина, глицина, гистидина, гидроксипролина, гидроксисерина, гидрокситирозина, гидроксилизина, изолейцина, лейцина, лизина, метионина, фенилаланина, пролина, серина, таурина, треонина, триптофана, тирозина, валина и их комбинаций.
13. Питательная композиция по п.12, в которой аминокислота является аминокислотой с разветвленной цепью, выбранной из группы, состоящей из изолейцина, лейцина, валина и их комбинаций.
14. Питательная композиция по п.1, которая дополнительно содержит соединение, выбранное из группы, состоящей из α-кетоглутарата, L-карнитина и их комбинаций.
15. Питательная композиция по п.1, которая является пероральной питательной добавкой или зондовым питанием.
16. Питательная композиция по п.1, которая является источником сбалансированного питания или несбалансированного питания.
17. Питательная композиция по любому из пп.1-16 для применения в:
i) стимулировании синтеза мышечного белка у индивидуума, нуждающегося в этом, или
ii) минимизации катаболизма мышечного белка у индивидуума, нуждающегося в этом, или
iii) сохранении мышечной массы тела у индивидуума, нуждающегося в этом, или
iv) снижении потерь костной ткани, индуцированных отсутствием регулярной физической нагрузки, у индивидуума, нуждающегося в этом, или
v) ослаблении атрофии скелетных мышц у индивидуума, нуждающегося в этом, или
vi) смягчения симптомов высокой уремической нагрузки у индивидуума, нуждающегося в этом.
18. Питательная композиция по п.17, в соответствии с которой индивидуум выбирается из группы, состоящей из пожилых индивидуумов, индивидуумов с болезненным состоянием и их сочетание.
19. Питательная композиция по п.18, в соответствии с которой пожилые индивидуумы включают индивидуумов с риском потери трудоспособности вследствие саркопении, немощности.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161476345P | 2011-04-18 | 2011-04-18 | |
US61/476,345 | 2011-04-18 | ||
PCT/EP2012/057094 WO2012143404A1 (en) | 2011-04-18 | 2012-04-18 | Nutritional compositions having alpha-hica and eicosapentaenoic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2013151090A true RU2013151090A (ru) | 2015-05-27 |
Family
ID=45976400
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013151085/13A RU2013151085A (ru) | 2011-04-18 | 2012-04-18 | ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ α-ГИДРОКСИИЗОКАПРОНОВУЮ КИСЛОТУ(α-HICA), И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
RU2013151083/13A RU2013151083A (ru) | 2011-04-18 | 2012-04-18 | ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ α-ГИДРОКСИИЗОКАПРОНОВУЮ КИСЛОТУ (α-HICA) И ЦИТРУЛЛИН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
RU2013151090/13A RU2013151090A (ru) | 2011-04-18 | 2012-04-18 | Питательные композиции, содержащие альфа-гидроксиизокапроновую кислоту и эйкозапентаеновую кислоту |
RU2013151087/13A RU2013151087A (ru) | 2011-04-18 | 2012-04-18 | Питательные композиции, содержащие альфа-гикк и альфа - кетоглутарат |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013151085/13A RU2013151085A (ru) | 2011-04-18 | 2012-04-18 | ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ α-ГИДРОКСИИЗОКАПРОНОВУЮ КИСЛОТУ(α-HICA), И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
RU2013151083/13A RU2013151083A (ru) | 2011-04-18 | 2012-04-18 | ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ α-ГИДРОКСИИЗОКАПРОНОВУЮ КИСЛОТУ (α-HICA) И ЦИТРУЛЛИН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013151087/13A RU2013151087A (ru) | 2011-04-18 | 2012-04-18 | Питательные композиции, содержащие альфа-гикк и альфа - кетоглутарат |
Country Status (13)
Country | Link |
---|---|
US (4) | US20140056862A1 (ru) |
EP (4) | EP2699113A1 (ru) |
JP (4) | JP2014512372A (ru) |
CN (4) | CN103458710A (ru) |
AU (4) | AU2012244749A1 (ru) |
BR (2) | BR112013026706A2 (ru) |
CA (4) | CA2832507A1 (ru) |
MX (4) | MX2013012231A (ru) |
PH (1) | PH12013502027A1 (ru) |
RU (4) | RU2013151085A (ru) |
SG (4) | SG194028A1 (ru) |
WO (4) | WO2012143404A1 (ru) |
ZA (4) | ZA201308604B (ru) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2583566E (pt) * | 2011-10-21 | 2015-11-13 | Nestec Sa | Micelas de proteína de soro de leite para aumentar a massa muscular e desempenho |
EP2583563A1 (en) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Whey protein micelles against muscle atrophy and sarcopenia |
ITBO20120226A1 (it) * | 2012-04-24 | 2013-10-25 | Alfa Wassermann Spa | Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso. |
CN103783532B (zh) * | 2012-10-29 | 2016-06-08 | 杭州纽曲星生物科技有限公司 | 一种抗老年性肌肉衰减的复合蛋白质粉及其制备方法 |
BR112015025490B1 (pt) * | 2013-04-15 | 2022-05-03 | Société des Produits Nestlé S.A. | Uso de uma fonte de aminoácidos em combinação com o estímulo muscular elétrico |
CN112931879A (zh) * | 2013-06-10 | 2021-06-11 | N·V·努特里奇亚 | 超重或肥胖成年人在体重减轻项目期间的肌肉保持 |
CN107223020A (zh) * | 2013-09-25 | 2017-09-29 | 胺细拉健康公司 | 用于预防和治疗糖尿病和肥胖症的组合物和制剂及其产生和用于葡萄糖和卡路里控制的方法 |
AU2014333977B2 (en) * | 2013-10-09 | 2019-12-19 | Société des Produits Nestlé S.A. | Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome |
CN103637212B (zh) * | 2013-12-13 | 2014-12-24 | 广东省农业科学院蚕业与农产品加工研究所 | 一种具有降血脂作用的管饲临床营养品及其制备方法 |
CN106061479B (zh) * | 2014-03-07 | 2019-04-23 | 味之素株式会社 | 虚弱预防剂 |
JPWO2015137387A1 (ja) * | 2014-03-11 | 2017-04-06 | 協和発酵バイオ株式会社 | 筋肉増強剤 |
EP3128859A1 (en) * | 2014-03-26 | 2017-02-15 | Abbott Laboratories | Nutritional supplement powder |
US20190054093A1 (en) * | 2014-04-04 | 2019-02-21 | Nektium Pharma Sl | Treatment of sarcopenia with ecdysteroids |
WO2015160262A1 (en) * | 2014-04-16 | 2015-10-22 | Amerikal Nutraceutical Corp | Anti-aging composition |
CN104027340B (zh) * | 2014-05-14 | 2018-08-24 | 田芳 | 一种含有三水合乳果糖组合物的可溶性粉剂及其制备方法 |
US20170196243A1 (en) * | 2014-06-03 | 2017-07-13 | Abbott Laboratories | Potato based protein mixtures and nutritional compositions comprising potato protein |
US11102994B2 (en) | 2014-08-21 | 2021-08-31 | Clearfast Inc. | Pre-operative carbohydrate-rich beverage composition and methods of treatment |
WO2016044167A1 (en) * | 2014-09-15 | 2016-03-24 | Abbott Laboratories | Methods for increasing muscle strength and mobility in subjects experiencing significant physical inactivity using gamma linolenic acid |
ES2960218T3 (es) * | 2014-10-14 | 2024-03-01 | Nestle Sa | Mejora en la funcionalidad del músculo de hombres ancianos |
US11040022B2 (en) * | 2015-02-05 | 2021-06-22 | William H. Cross, III | Compositions and methods for pain relief |
NL2015032B1 (en) * | 2015-06-26 | 2017-01-24 | Vitalnext B V | Compositions and methods for the treatment of malnutrition. |
WO2017075289A1 (en) | 2015-10-27 | 2017-05-04 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
RU2614881C1 (ru) * | 2015-12-29 | 2017-03-30 | Общество с ограниченной ответственностью "Мобильный доктор" | Комплекс биологически активных веществ, защищающих спортсменов от перетренированности |
WO2017114686A1 (en) * | 2015-12-30 | 2017-07-06 | Nestec S.A. | Method for determining fat free body mass |
CN108697139A (zh) | 2016-02-29 | 2018-10-23 | 雅培制药有限公司 | 营养补充粉 |
US11612632B2 (en) | 2017-04-25 | 2023-03-28 | William H. Cross, III | Compositions and methods for treatment of prediabetes |
NZ746681A (en) * | 2016-05-20 | 2022-07-01 | Nestle Sa | Nutritional compositions for cardiac protection in companion animals |
CN106213522A (zh) * | 2016-08-05 | 2016-12-14 | 郑家福 | 营养保健品 |
RU2635373C1 (ru) * | 2016-08-25 | 2017-11-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Биологически активная добавка для повышения общей работоспособности |
CN109803673A (zh) | 2016-09-13 | 2019-05-24 | 阿勒根公司 | 非蛋白质梭菌毒素组合物 |
AU2017361804B2 (en) * | 2016-11-16 | 2021-09-09 | Fresenius Kabi Deutschland Gmbh | Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
KR20180081361A (ko) * | 2017-01-06 | 2018-07-16 | 연세대학교 산학협력단 | 인돌-3-카비놀 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물 |
EP3615029A4 (en) | 2017-04-25 | 2021-04-21 | Buck Institute for Research on Aging | FORMULATIONS TO EXTEND LIFE AND HEALTH LIFETIME |
EP3641566A1 (en) | 2017-06-21 | 2020-04-29 | Abbott Laboratories | Methods for increasing growth of beneficial bacteria in the gastrointestinal tract |
CN107242572A (zh) * | 2017-07-06 | 2017-10-13 | 广州彤博士健康科技有限公司 | 营养补充剂及制备方法 |
WO2019036471A1 (en) | 2017-08-14 | 2019-02-21 | Axcella Health Inc. | AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE |
CN107616505B (zh) * | 2017-10-24 | 2020-12-25 | 精晶药业股份有限公司 | 一种含有鸟氨酸酮戊二酸的保健品及其制备方法 |
PL238310B1 (pl) * | 2017-10-31 | 2021-08-09 | Top Energy Set Spolka Z Ograniczona Odpowiedzialnoscia | Preparat leczniczy oraz sposób jego uzyskiwania |
US11304971B2 (en) | 2018-01-31 | 2022-04-19 | William H. Cross, III | Metformin compositions and methods for treatment of diabetes |
US11154523B2 (en) | 2018-01-31 | 2021-10-26 | William H. Cross, III | Compositions and methods for treatment of diabetic neuropathies |
US11351188B2 (en) | 2018-01-31 | 2022-06-07 | William H. Cross, III | Folic compositions and methods for treatment of diabetic neuropathies |
AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
JP2022502489A (ja) | 2018-09-25 | 2022-01-11 | ポンス デ レオン ヘルス デジグネイテッド アクティビティ カンパニー | αケトグルタル酸カルシウムを製造するためのプロセス |
WO2020106746A1 (en) * | 2018-11-19 | 2020-05-28 | Heh Research & Development Services, Inc. | Biologic enhancement formulation |
KR102171518B1 (ko) * | 2019-02-21 | 2020-10-29 | 한양대학교 에리카산학협력단 | 지골피 추출물을 유효성분으로 함유하는 근 위축 예방 또는 치료용 조성물 |
MX2021013777A (es) * | 2019-05-31 | 2021-12-10 | Nestle Sa | Mezcla nutricional a base de mct para proporcionar beneficios para la salud en animales. |
WO2020252005A1 (en) * | 2019-06-10 | 2020-12-17 | Buck Institute For Research On Aging | Methods and compositions for altering senescence associated secretory phenotype |
CN110226756A (zh) * | 2019-06-18 | 2019-09-13 | 山东理工大学 | 预防和缓解2型糖尿病患者肌少症的蛋白组件及制备方法 |
TWI774966B (zh) * | 2019-06-25 | 2022-08-21 | 生合生物科技股份有限公司 | 胚芽乳桿菌bcrc 910734用於提升老年個體的肌力以及治療肌肉減少症的用途 |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US20210196772A1 (en) * | 2019-12-27 | 2021-07-01 | Grove Collaborative, Inc. | Confections for skin protection: compositions, methods for making, and applications thereof |
MX2022011963A (es) * | 2020-03-30 | 2022-10-20 | Gervais Danone Sa | Composiciones de leche fermentada para su uso en metodos de suplementacion nutricional. |
FI129515B (en) * | 2020-11-06 | 2022-03-31 | Salarusta Oy | FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY |
CN112899204B (zh) * | 2021-03-19 | 2022-06-28 | 杭州百芮生物科技有限公司 | 一种益生菌冻干外壳复合保护剂及其应用 |
CN113398144B (zh) * | 2021-07-27 | 2022-04-01 | 陈玉松 | 核苷酸混合物在制备预防或缓解老年肌少症制剂中的应用 |
CN114029085B (zh) * | 2021-12-06 | 2024-02-27 | 中触媒新材料股份有限公司 | 一种烯烃环氧化催化剂及其制备方法和应用 |
WO2023121696A1 (en) * | 2021-12-20 | 2023-06-29 | Schneider Todd C | Formulation and treatment for extended micronutrient therapy |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2335215B2 (de) * | 1972-07-13 | 1979-04-05 | The Johns Hopkins University, Baltimore, Md. (V.St.A.) | Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen |
GB1442154A (en) * | 1973-04-30 | 1976-07-07 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body |
GB1444621A (en) * | 1973-04-30 | 1976-08-04 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids |
GB1511302A (en) * | 1974-04-15 | 1978-05-17 | Univ Johns Hopkins | Pharmaceutical compositions comprising amino acid analogues |
US4752619A (en) | 1985-12-23 | 1988-06-21 | The Johns Hopkins University | Nutritional supplement for treatment of uremia |
SE8803144L (sv) * | 1988-09-07 | 1990-03-08 | Kabivitrum Ab | Energisubstrat |
SE9201584D0 (sv) * | 1992-05-20 | 1992-05-20 | Vinnars Erik Ab | Use of alpha-ketoglutarate |
US5646187A (en) * | 1992-05-20 | 1997-07-08 | Ab Erik Vinnars | Use of alpha-ketoglutarate |
SE0201713D0 (sv) * | 2001-11-23 | 2002-06-06 | Gramineer Internat Ab | New methods and use III |
US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
US8795693B2 (en) * | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
WO2005107735A2 (en) * | 2004-04-30 | 2005-11-17 | Pump Formulations, Ltd. | Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, incresing nutrient delivery and/or promoting increased vascular response in a |
FI20045395A (fi) * | 2004-10-21 | 2006-04-22 | Elmomed Ltd Oy | Ravintoainelisä ja sen käyttö |
WO2007082914A2 (en) * | 2006-01-19 | 2007-07-26 | Entress Ab | Method of diagnosis and method of treatment |
WO2006127936A2 (en) * | 2005-05-23 | 2006-11-30 | Cadbury Adams Usa Llc | Taste potentiator compositions and edible confectionery and chewing gum products containing same |
CN101179943B (zh) * | 2005-05-23 | 2013-06-26 | 卡夫食品环球品牌有限责任公司 | 填充液体的咀嚼型胶基糖组合物 |
EP1774973A1 (en) * | 2005-10-12 | 2007-04-18 | Nutricia N.V. | Leucine rich composition |
CA2628265A1 (en) * | 2005-11-08 | 2007-05-18 | Multi Formulations Ltd. | The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance |
DE602006008985D1 (de) * | 2005-12-16 | 2009-10-15 | Nutricia Nv | Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund |
AU2006338839A1 (en) * | 2006-02-23 | 2007-08-30 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
MX2008012072A (es) * | 2006-03-23 | 2008-11-25 | Nestec Sa | Suplemento nutricional alto en calorias. |
EP2612666A3 (en) * | 2006-04-04 | 2013-10-02 | Nestec S.A. | Treatments using citrulline |
CN101415414B (zh) * | 2006-04-04 | 2013-06-12 | 雀巢产品技术援助有限公司 | 瓜氨酸在制备治疗矫正脓毒症患者中精氨酸缺乏的药物中的用途 |
PL379512A1 (pl) * | 2006-04-21 | 2007-10-29 | Sgp & Sons Ab | Nowe metody i ich zastosowanie |
AR062305A1 (es) * | 2006-08-09 | 2008-10-29 | Iams Company | Metodos para mejorar la salud osea y la salud muscular |
FR2913885B1 (fr) * | 2007-03-22 | 2012-07-20 | Univ Paris Descartes | Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines |
AU2007358961A1 (en) * | 2007-09-11 | 2009-03-19 | Northern Innovations And Formulations Corp. | Composition and method for increasing the anabolic state of muscle cells |
CA2610820A1 (en) * | 2007-12-12 | 2008-12-29 | Michele Molino | Method for maintaining physiological ph levels during intensive physical exercise |
US20090156647A1 (en) * | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | Method for maintaining physiological pH levels during intensive physical exercise |
WO2010002242A1 (en) * | 2008-07-02 | 2010-01-07 | N.V. Nutricia | Nutritional composition for improving muscle function and daily activity |
JP2010105946A (ja) * | 2008-10-29 | 2010-05-13 | Nof Corp | 筋タンパク質増強剤及びこれを含む医薬品または食品 |
WO2010108016A2 (en) * | 2009-03-18 | 2010-09-23 | Healthspan Solutions, Llc | Compositions and methods for sparing muscle in renal insufficiency and during hemodialysis |
WO2010137944A1 (en) * | 2009-05-27 | 2010-12-02 | N.V. Nutricia | Treatment of hypercalcaemia |
CN102647990A (zh) * | 2009-07-20 | 2012-08-22 | 雀巢产品技术援助有限公司 | 减少功能状态损失的方法 |
CN102481009A (zh) * | 2009-08-13 | 2012-05-30 | 雀巢产品技术援助有限公司 | 包含外源性核苷酸的营养组合物 |
BR112012005783A2 (pt) * | 2009-09-14 | 2017-05-30 | Nestec Sa | composições nutricionais incluindo vitamina k2 exógena |
-
2012
- 2012-04-18 RU RU2013151085/13A patent/RU2013151085A/ru not_active Application Discontinuation
- 2012-04-18 AU AU2012244749A patent/AU2012244749A1/en not_active Abandoned
- 2012-04-18 US US14/112,746 patent/US20140056862A1/en not_active Abandoned
- 2012-04-18 WO PCT/EP2012/057094 patent/WO2012143404A1/en active Application Filing
- 2012-04-18 MX MX2013012231A patent/MX2013012231A/es unknown
- 2012-04-18 CA CA2832507A patent/CA2832507A1/en not_active Abandoned
- 2012-04-18 WO PCT/EP2012/057095 patent/WO2012143405A1/en active Application Filing
- 2012-04-18 CA CA2831001A patent/CA2831001A1/en not_active Abandoned
- 2012-04-18 BR BR112013026706A patent/BR112013026706A2/pt not_active IP Right Cessation
- 2012-04-18 BR BR112013026539A patent/BR112013026539A2/pt not_active IP Right Cessation
- 2012-04-18 JP JP2014505605A patent/JP2014512372A/ja active Pending
- 2012-04-18 CA CA2832150A patent/CA2832150A1/en not_active Abandoned
- 2012-04-18 JP JP2014505604A patent/JP2014512371A/ja active Pending
- 2012-04-18 WO PCT/EP2012/057093 patent/WO2012143403A1/en active Application Filing
- 2012-04-18 SG SG2013073465A patent/SG194028A1/en unknown
- 2012-04-18 CN CN2012800179097A patent/CN103458710A/zh active Pending
- 2012-04-18 EP EP12719308.4A patent/EP2699113A1/en not_active Withdrawn
- 2012-04-18 EP EP12719307.6A patent/EP2699112A1/en not_active Withdrawn
- 2012-04-18 US US14/112,779 patent/US20140056863A1/en not_active Abandoned
- 2012-04-18 AU AU2012244750A patent/AU2012244750A1/en not_active Abandoned
- 2012-04-18 WO PCT/EP2012/057092 patent/WO2012143402A1/en active Application Filing
- 2012-04-18 RU RU2013151083/13A patent/RU2013151083A/ru not_active Application Discontinuation
- 2012-04-18 JP JP2014505603A patent/JP2014519483A/ja active Pending
- 2012-04-18 EP EP12715104.1A patent/EP2699110A1/en not_active Withdrawn
- 2012-04-18 CA CA2831165A patent/CA2831165A1/en not_active Abandoned
- 2012-04-18 MX MX2013012228A patent/MX2013012228A/es unknown
- 2012-04-18 MX MX2013012230A patent/MX2013012230A/es unknown
- 2012-04-18 RU RU2013151090/13A patent/RU2013151090A/ru not_active Application Discontinuation
- 2012-04-18 EP EP12718133.7A patent/EP2699111A1/en not_active Withdrawn
- 2012-04-18 CN CN201280019059.4A patent/CN103491804A/zh active Pending
- 2012-04-18 CN CN2012800190607A patent/CN103476275A/zh active Pending
- 2012-04-18 SG SG2013073986A patent/SG194065A1/en unknown
- 2012-04-18 JP JP2014505606A patent/JP2014511890A/ja active Pending
- 2012-04-18 SG SG2013071386A patent/SG193933A1/en unknown
- 2012-04-18 SG SG2013071626A patent/SG193938A1/en unknown
- 2012-04-18 CN CN2012800190556A patent/CN103476274A/zh active Pending
- 2012-04-18 AU AU2012244748A patent/AU2012244748B2/en not_active Ceased
- 2012-04-18 US US14/112,785 patent/US20140044685A1/en not_active Abandoned
- 2012-04-18 AU AU2012244751A patent/AU2012244751A1/en not_active Abandoned
- 2012-04-18 US US14/112,744 patent/US20140037604A1/en not_active Abandoned
- 2012-04-18 RU RU2013151087/13A patent/RU2013151087A/ru not_active Application Discontinuation
-
2013
- 2013-09-30 PH PH12013502027A patent/PH12013502027A1/en unknown
- 2013-10-18 MX MX2013012229A patent/MX2013012229A/es not_active Application Discontinuation
- 2013-11-15 ZA ZA2013/08604A patent/ZA201308604B/en unknown
- 2013-11-15 ZA ZA2013/08606A patent/ZA201308606B/en unknown
- 2013-11-15 ZA ZA2013/08605A patent/ZA201308605B/en unknown
- 2013-11-15 ZA ZA2013/08607A patent/ZA201308607B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2013151090A (ru) | Питательные композиции, содержащие альфа-гидроксиизокапроновую кислоту и эйкозапентаеновую кислоту | |
Kumar et al. | Microalgae as a sustainable source of edible proteins and bioactive peptides–Current trends and future prospects | |
JP2014519483A5 (ru) | ||
Cudennec et al. | Peptides from fish and crustacean by-products hydrolysates stimulate cholecystokinin release in STC-1 cells | |
Sroyraya et al. | Nutritional components of the sea cucumber Holothuria scabra | |
AU2012299126B2 (en) | Compositions and methods for use in promoting lean body mass | |
KR20100057630A (ko) | 아미노산 및 펩티드 제품 | |
Ichimura et al. | Antihypertensive effect of enzymatic hydrolysate of collagen and Gly-Pro in spontaneously hypertensive rats | |
RU2008117138A (ru) | Способы и композиции для улучшения когнитивной функции | |
RU2008132813A (ru) | Лечение пациентов, подвергнутых стрессу | |
Jensen et al. | Nutritional content and bioactive properties of wild and farmed cod (Gadus morhua L.) subjected to food preparation | |
AU2016348294B2 (en) | Compositions containing preen oil and methods of use thereof | |
Abachi et al. | Isolation of immunomodulatory biopeptides from Atlantic Mackerel (Scomber scombrus) protein hydrolysate based on molecular weight, charge, and hydrophobicity | |
Mustafa et al. | Effect of garlic (Allium sativum)-supplemented diet on growth performance, body composition and fatty acid profile of rainbow trout (Oncorhynchus mykiss) | |
Kłobukowski et al. | Selected parameters of nutritional and pro-health value in the common carp (Cyprinus carpio L.) muscle tissue | |
Manoharan et al. | Comparative assessment of nutritional composition in raw and cooked Indian freshwater fish Lepidocephalus thermalis (V.) | |
RU2015133023A (ru) | Активация адипонектина с использованием гидролизата казеина | |
Turnagöl et al. | Alternative protein sources in sustainable sports nutrition | |
WO2018066394A1 (ja) | 筋肉を柔軟にするための組成物 | |
Saad et al. | Amino acids profile of some economically important marine and freshwater fish from Sudan | |
Kim et al. | Preparation and characterization of canned skipjack tuna Katsuwonus pelamis as a health food | |
Sahib et al. | Effect of Supplementing different sources and levels of Omega-3 in ration on body weights of broilers | |
Engin et al. | The effects of combined use of soybean extract and mixture of several plant oils on the growth parameters and whole body and tissue amino acids and fatty acids compositions in juvenile Nile tilapia (Oreochromis niloticus Linnaeus, 1758) | |
UA139425U (uk) | Паштет печінковий з лляним та соняшниковим насінням | |
RU2023128037A (ru) | Пероральные или энтеральные пищевые композиции и способы их изготовления |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20150420 |